INTRODUCTION
TRPM7 and the closely related TRPM6 are bifunctional proteins that combine a Ca 2+ -and Mg 2+ -permeable cation channel with an intrinsic protein kinase domain [1] . Mutations in the gene encoding TRPM6 result in autosomal-recessive hypomagnesaemia with secondary hypocalcaemia [2] . Deletion of TRPM7 in cultured cells is lethal but can be rescued by supplementing the growth media with high levels of magnesium [3, 4] . In addition to its crucial function in cellular Mg 2+ homoeostasis, TRPM7 plays a key role in anoxic neuronal cell death and in the regulation of actomyosin contractility and cell adhesion [5] [6] [7] . The ability of TRPM6/7 to influence cell physiology is likely to depend on a combination of both its ion channel and kinase activities.
The kinase domain fused to the C-terminus of TRPM6/7 belongs to a small but evolutionarily conserved family of atypical serine/threonine protein kinases termed alpha-kinases [8] [9] [10] . The alpha-kinase catalytic domain shares little or no primary sequence identity with the catalytic domain found in typical ePKs (eukaryotic protein kinases); however, structural analysis of the TRPM7 alpha-kinase domain shows that it adopts an overall fold similar to that of the ePKs [11] . Functional counterparts for many of the invariant catalytic residues present in the ePK active site can be identified in the alpha-kinase active site, suggesting that the alpha-kinases and ePKs share a common, albeit distant, ancestor [11] [12] [13] .
The TRPM6/7 alpha-kinase domain is involved in regulating TRPM6/7 channel activity as well as the phosphorylation of downstream effectors. Mutations that abolish kinase activity do not affect the activity of the TRPM6/7 channel activity but do influence the ability of free Mg 2+ and nucleotides to suppress channel activity [4, [14] [15] [16] . The alpha-kinase domain autophosphorylates more than 40 sites within the C-terminal region of TRPM6/7, resulting in enhanced interactions with non-muscle myosin II [17] . Both non-muscle myosin II and annexin I are phosphorylated by the TRPM7 alpha-kinase domain [18, 19] . The sites targeted by TRPM7 in myosin II are located in the tail region and act to destabilize assembly into bipolar filaments. Activation of TRPM7 kinase activity therefore reduces myosin II-based contractility, resulting in the remodelling of the cell cytoskeleton and the transformation of focal adhesions into podosomes [7] . Remarkably, alpha-kinases were initially identified in Dictyostelium discoideum as MHCKs (myosin II heavy-chain kinases) that drive myosin II filament disassembly by targeting sites in the tail [20, 21] . Thus the connection between alpha-kinases and myosin II has been highly conserved throughout evolution.
Currently, little is known concerning the mechanisms that regulate the activity of the TRPM6/7 alpha-kinase domain. TRPM7 kinase activity is strongly enhanced by millimolar levels of free Mg 2+ and Mn 2+ , suggesting that opening and closing of the ion channel domain to modulate the local bivalent cation concentration may be one means to regulate kinase activity [4, 15, 22] . In the present study, we show that dimer interactions play a critical role in regulating the activity of the TRPM7 alphakinase domain. The TRPM7 alpha-kinase domain assembles into a homodimer through the exchange of a 27-residue-long N-terminal sequence that encompasses residues 1551-1577 [11] . Here we show that the N-terminal segment can be divided into Abbreviations used: eEF-2K, eukaryotic elongation factor-2 kinase; ePK, eukaryotic protein kinase; GST, glutathione transferase; MBP, myelin basic protein; MHCK, myosin II heavy-chain kinase; TRP, transient receptor potential; TRPM, TRP melastatin. 1 To whom correspondence should be addressed (email coteg@queensu.ca).
an 'activation sequence', encompassing residues 1553-1562, that is required for kinase activity but not dimer formation, and a 'dimerization sequence', encompassing residues 1563-1570, that is critical for both dimer formation and activity. It is proposed that key residues within the activation sequence, including Tyr-1553 and Arg-1558, support kinase activity by helping to position a catalytic loop in the second subunit. In addition, it is demonstrated that the N-terminal segment of TRPM6 is capable of binding to and activating TRPM7. These results raise the possibility that alterations in the conformation of the exchanged Nterminal segment, brought about either by covalent modifications or protein interactions, could regulate TRPM7 kinase activity.
MATERIALS AND METHODS

Construction of expression plasmids
All DNA manipulations were carried out according to standard techniques [23] . DNA encoding residues 1548-1863 of mouse TRPM7 (NM_021450) were obtained by PCR using a mouse brain cDNA library (Clontech) as a template. DNA fragments encoding N-terminal truncated versions of the TRPM7 alpha-kinase domain or site-directed mutants were generated by PCR. The PCR products were cloned in-frame into the NcoI and EcoRI sites of pET28a (Novagen) to obtain expression constructs containing a C-terminal His tag. To test for heterodimer formation, residues 1711-2028 of mouse TRPM6 (NM_153417) were obtained by PCR using IMAGE (Integrated Molecular Analysis of Genomes and their Expression) consortium clone 100063075 (Open Biosystems) as a template. Bicistronic constructs designed to co-express GST (glutathione transferase)-TRPM6 with TRPM6-FLAG, GST-TRPM7 with TRPM7-His and GST-TRPM6 with TRPM7-His were created. In each case, the upstream gene product was fused in-frame to GST by cloning into the BamHI and EcoRI cloning sites of pGEX-4T3. Subsequently, PCR products of TRPM6 and TRPM7, each containing a 5 -ribosome-binding site and either a C-terminal His tag for TRPM7 or a C-terminal FLAG tag for TRPM6, were inserted downstream into the EcoRI and SalI sites. Activity reconstitution assays used bicistronic constructs that were created to express both a His-tagged TRPM7-1577 and GST fused either to the N-terminal exchanged segment of TRPM7 (residues 1548-1576) or TRPM6 (residues 1711-1740). First, DNA encoding residues of the N-terminal exchange segments of TRPM7 and TRPM6 were fused in-frame to the 5 -end of DNA encoding GST with a 3 stop codon. These constructs, or GST alone, were then cloned into the NcoI/BamHI sites of pET28a. Next, a DNA fragment encoding TRPM7 residues 1577-1863 with a 5 -ribosome-binding site was generated by PCR and cloned in-frame into the BamHI and XhoI sites of the pET28 vectors, resulting in the addition of a C-terminal His tag. A construct designed to solely express the N-terminal exchanged segment of TRPM7 fused to GST [GST-(1548-1576)] was created as above, excluding the addition of the second downstream gene product.
Protein purification
Recombinant fusion proteins were expressed in Escherichia coli strain BL21-DE3 (Novagen). Bacteria were grown at 37 • C to an attenuance (D 600 ) of 0.6-1.0, then cooled to 24
• C and induced for 10-15 h using a final concentration of 1 mM isopropyl β-D-thiogalactoside. Cells were lysed by sonication in icecold lysis buffer (500 mM NaCl, 5 mM imidazole and 20 mM Tris/HCl, pH 8.0) containing one Complete TM Mini EDTAfree protease inhibitor cocktail tablet (Roche Diagnostics) per 50 ml of buffer. The supernatant obtained after centrifugation at 75 000 g for 1 h was applied to a column of His-Bind resin (Novagen). His-tagged TRPM7 constructs were eluted with 250 mM NaCl, 500 mM imidazole and 20 mM Tris/HCl (pH 8.0), dialysed against 50 mM NaCl and 20 mM Tris/HCl (pH 7.5) and applied to a Q-Sepharose column. The column was eluted stepwise with a buffer containing 175, 200 and 300 mM NaCl. Fractions containing the TRPM7 constructs were pooled and dialysed against 50 mM NaCl, 1 mM dithiothreitol and 20 mM Tris/HCl (pH 7.4). Cells expressing bicistronic constructs were lysed in ice-cold TBS (150 mM NaCl and 50 mM Tris/HCl, pH 7.4) containing 0.2 mg/ml lysozyme and one Complete TM Mini protease inhibitor cocktail tablet per 50 ml of buffer. After centrifugation as described above, cell extracts were applied to a glutathione-Sepharose column (GE Healthcare). The column was washed with PBS and eluted with 20 mM glutathione in PBS. After SDS gel electrophoresis, proteins were visualized by staining with Coomassie Blue and band densities were quantified using ImageJ software (National Institutes of Health, Bethesda, MD, U.S.A.). Immunoblot analysis was performed using a His-Probe antibody (Santa Cruz Biotechnology), anti-GST antibody (Sigma-Aldrich) or anti-FLAG M2 antibody (Sigma-Aldrich) and an ECL ® (enhanced chemiluminescence) system (GE Healthcare).
Kinase reactions
Phosphorylation assays contained 50 μg/ml of kinase and 1 mg/ml MBP (myelin basic protein) and were performed at 25
• C in kinase buffer (2 mM MgCl 2 , 1 mM dithiothreitol, 0.25 mM ATP and 20 mM Tes, pH 7.0) incorporating [γ -
32 P]ATP (NEN PerkinElmer) at a specific activity of 200-500 c.p.m./pmol of ATP. Aliquots of 40 μl were removed from the reaction after 30 min and added to 10 μl of boiling hot 5 × SDS sample buffer (5 % SDS, 1 % 2-mercaptoethanol and 300 mM Tris/HCl, pH 6.8, and a trace of Bromophenol Blue). Following SDS/PAGE and staining with Coomassie Blue, the MBP band was excised from the gel and counted in a Beckman LS 9000 scintillation counter using ScintiVerse Universal LS cocktail (Fisher Scientific). Incorporation of 32 P into MBP was linear up to the 30 min time point. Under these assay conditions the TRPM7-1548 construct exhibited a phosphotransferase rate of 3 × 10 − 3 s − 1 . Data sets are representative of at least eight kinase assays from two independent protein preparations and were analysed using a twotailed Student's t test.
Gel-filtration chromatography
Gel-filtration chromatography was performed using a Pharmacia FPLC system and a HiPrep Sephacryl 200 HR column (GE Healthcare) equilibrated in 150 mM NaCl and 50 mM NaPO 4 (pH 7.4). The column was calibrated using blue dextran, RNase A, chymotrypsinogen A, ovalbumin, BSA and aldolase. A standard curve was constructed by plotting the partition coefficients (K av ) of the proteins against the logarithm of the proteins' molecular masses.
RESULTS
The X-ray crystal structure of the TRPM7 alpha-kinase domain shows that the N-terminal sequence (residues 1551-1577) of one subunit interacts with the core alpha-kinase domain of the other subunit ( Figure 1A ). To investigate the functional role of the exchanged segment, a series of TRPM7 alpha-kinase domain N-terminal truncation constructs were prepared. The longest construct, termed TRPM7-1548, started at Asp-1548 and contained the full-length exchanged segment, whereas the shortest construct, termed TRPM7-1577, started at Gly-1577 and encoded only the core alpha-kinase domain ( Figure 1B ). All of the truncation constructs were recovered as soluble proteins of the expected size when expressed in E. coli as His-tagged proteins (Figure 2A ). Kinase assays showed that the catalytic activity of the TRPM7 alpha-kinase domain was not impacted by the removal of residues up to and including Tyr-1552 ( Figure 2B) . Surprisingly, the deletion of a single additional amino acid, Tyr-1553, resulted in the loss of greater than 90 % of catalytic activity. Further truncation to Arg-1563 or Gly-1577 completely abolished the catalytic activity of the TRPM7 alpha-kinase domain ( Figure 2B ). The results demonstrate that interactions between residues 1553-1562 of the exchanged N-terminal segment and the core alphakinase domain of the second subunit are essential to support catalytic activity.
The ability of the TRPM7 alpha-kinase domains to assemble into dimers was examined using gel-filtration chromatography. TRPM7-1548, TRPM7-1554 and TRPM7-1563 eluted from the column as single peaks with an apparent molecular mass approximately twice that of their calculated molecular mass ( Figure 2C and Table 1 ). TRPM7-1577 eluted from the gel-filtration column as a single peak with an apparent molecular mass close to its calculated molecular mass ( Figure 2C and Table 1 ). The results show that truncation of the N-terminus to Arg-1563 did not prevent dimer formation even though it abolished the catalytic activity of the TRPM7 alpha-kinase domain. Conversely, residues 1563-1577 of the exchanged segment are sufficient to mediate dimer assembly but do not support kinase activity. Table 1 .
Examination of the TRPM7 structure shows that two residues within the 1553-1562 sequence are primarily responsible for dimer interactions with the second subunit: Tyr-1553 and Arg-1558 ( Figures 3A and 3B ). Tyr-1553 forms a hydrogen bond via a water molecule with Glu-1760 in the other subunit and makes nonpolar contacts with the side chains of Tyr-1756 and Thr-1757 in the other subunit. To investigate the significance of these interactions, Tyr-1553 was mutated to phenylalanine, leucine and alanine in the context of the TRPM7-1548 construct. The mutant proteins were isolated from E. coli and assayed for kinase activity ( Figures 4A  and 4B ). The Y1553F mutant was 70 % as active as the wildtype TRPM7-1548 construct, whereas the Y1553L and Y1553A mutants exhibited 50 and 30 % of wild-type activity. Arg-1558 in the exchanged segment forms a salt bridge with Glu-1760 in the other subunit ( Figure 3B ). Mutation of either Arg-1558 or Glu-1760 to alanine resulted in the loss of 85 % of kinase activity ( Figure 4B) . A double mutant, in which both Arg-1558 and Glu-1760 were replaced with alanine, exhibited less than 10 % of wildtype activity ( Figure 4B) . Gel-filtration analysis demonstrated that the mutation of Arg-1558 to alanine did not impair dimer formation ( Table 1 ). The results demonstrate that interactions mediated by Tyr-1553 and Arg-1558 in the exchanged segment play a key role in maintaining the TRPM7 alpha-kinase domain of the second subunit in a catalytically competent conformation.
TRPM7 and TRPM6 can interact to form a functional heteromeric channel [24] [25] [26] . The N-terminal exchanged segments of TRPM7 and TRPM6 exhibit a high degree of sequence identity starting at Tyr-1553 (Tyr-1711 in TRPM6), raising the possibility that the two kinase domains may be able to assemble into active heterodimers ( Figure 5A ). To examine heterodimer formation, His-tagged TRPM7-1548 was co-expressed in E. coli with GST-TRPM7-1548 or GST-TRPM6 (residues 1711-2028). Affinity purification of the cell lysates over a glutathione-Sepharose column showed that the His-tagged TRPM7-1548 formed a homodimer with GST-TRPM7-1548 and a heterodimer with the GST-TRPM6 alpha-kinase domain ( Figure 5B ). A GST-tagged and a FLAG-tagged TRPM6 alpha-kinase domain were also able to assemble into a homodimer ( Figure 6B ).
The ability of an independently expressed N-terminal exchanged segment to rescue the catalytic activity of the monomeric TRPM7-1577 alpha-kinase domain was examined. For these experiments, the exchanged segment of TRPM7 (residues 1548-1576) was fused to the N-terminus of GST. Addition of GST alone did not activate TRPM7-1577, whereas addition of the purified GST-(1548-1576) fusion protein resulted in the recovery of 13 % of wild-type activity ( Figure 6A ). The activity curve yielded an apparent K d of 1.4 μM for the interaction between GST-(1548-1576) and TRPM7-1577. A GST-(1548-1576) fusion protein in which the critical Arg-1558 was mutated to alanine resulted in the recovery of only 3 % of wild-type activity ( Figure 6A) .
In a second set of experiments, GST or GST-(1548-1576) was co-expressed with His-tagged TRPM7-1577 in E. coli. Purification of the cell lysates over a glutathione-Sepharose column, followed by immunoblot analysis with an anti-His tag antibody, demonstrated that TRPM7-1577 formed a complex with GST-(1548-1576) but not with GST ( Figure 6B ). TRPM7-1577 also formed a complex with a GST fusion protein containing the N-terminal exchanged segment of TRPM6 (residues 1711-1740) ( Figure 6C ). Assays of the complexes, corrected for the amount of TRPM7-1577 present, showed that TRPM7-1577 complexed with the N-terminal segment of either TRPM7 or TRPM6 recovered almost full catalytic activity ( Figure 6D ). Gel-filtration analysis of the TRPM7-1577-GST-(1548-1576) complex yielded a molecular mass close to 100 kDa, which is consistent with a dimer of GST-(1548-1576) bound to one molecule of TRPM7-1577 (Table 1) . Taken together, the results show that association with an N-terminal segment is sufficient to restore the catalytic activity of the TRPM7 alpha-kinase domain. Moreover, the N-terminal exchanged segments of TRPM6 and TRPM7 seem to be functionally interchangeable.
The role played by individual residues in dimer formation was examined by incorporating mutations into the N-terminal segment of TRPM7 fused to GST [GST- (1548-1576) ]. The mutant forms of GST-(1548-1576) were co-expressed with Histagged TRPM7-1577 in E. coli and isolated from cell extracts by chromatography over a glutathione-Sepharose column. The interaction of the N-terminal segment with TRPM7-1577 was not affected by the mutation of Tyr-1553, Ser-1554 or Pro-1572 to alanine, but was abolished by the mutation of Leu-1562, Ile-1568 or Phe-1570 to alanine ( Figure 7A ). The expression level of TRPM7-1577 was elevated in cells co-expressing a dimercompetent form of the GST-(1548-1576) segment, suggesting that dimer interactions increase the stability of the alpha-kinase domain. All three of the mutations that eliminated dimer formation also abolished kinase activity when incorporated into the TRPM7-1548 construct ( Figure 7B ). The Ser-1554 to alanine mutation lowered kinase activity by 70 %, perhaps due to an effect of the orientation of Tyr-1553, whereas the Pro-1572 to alanine substitution slightly increased kinase activity ( Figure 7B ).
DISCUSSION
Both the ion channel and kinase activities of TRPM7 have important roles in the regulation of cell function. To date, little is known about how the catalytic activity of the TRPM7 alpha-kinase domain is controlled. Here we show that dimer interactions between the alpha-kinase domain of one subunit and the exchanged N-terminal segment of the other subunit are His-tagged TRPM7-1548 (TRPM7-His) was co-expressed in E. coli with GST (top panel), GST-TRPM7-1548 (GST-TRPM7) (second panel) or GST fused to TRPM6 residues 1711-2028 (GST-TRPM6) (third panel). GST-TRPM6 was also co-expressed with FLAG-tagged TRPM6-(1711-2028) (TRPM6-FLAG) (bottom panel). Cell lysates were purified over a glutathione-Sepharose column as described in the Materials and methods section. Samples of the lysate (2.5 μg), flow through (FT; 5 μg), column washes (20 μl per lane) and material eluted with 20 mM glutathione (20 μl per lane) were subjected to SDS/PAGE and immunoblotted (IB) using antibodies against the His tag, FLAG tag or GST as indicated.
essential for activity. In addition, we define several of the key inter-subunit interactions required for kinase activity and dimer formation.
Truncation studies showed that residues N-terminal to Tyr-1553 are not required for the catalytic activity of the TRPM7 alpha-kinase domain ( Figure 2B ). This result is consistent with previous work showing that TRPM7 alpha-kinase domains that start at residue 1180, 1403 or 1548 exhibit a high level of catalytic activity [17, 22] . It is also consistent with the crystal structure of the TRPM7 alpha-kinase domain dimer, which shows that Tyr-1551 and Tyr-1552 do not form stable contacts with the other subunit [11] . The side chains of Tyr-1551 and Tyr-1552 in the exchanged segment of subunit B contact Trp-1752, Tyr-1756 and Arg-1758 in subunit A; however, at the other dimer interface, the side chains of Tyr-1551 and Tyr-1552 are oriented into solution and away from subunit B ( Figure 3B ). The catalytic activity of the TRPM7 alpha-kinase domain was decreased by more than 90 % by the removal of Tyr-1553 and was abolished by truncation to relative to that of TRPM7-1548 (*P < 0.005). The amount of TRPM7-1577 present in the complex was quantified by densitometry of Coomassie Blue-stained gels using ImageJ software. Relative activity of the GST control was measured as a function of total protein compared with GST-TRPM7-(1548-1576). Kinase assays were carried out as described in the Materials and methods section.
Arg-1563. Unexpectedly, truncation to Arg-1563 did not impair dimer formation. Therefore residues 1553-1562 of the N-terminal segment function specifically as an 'activation sequence' that is needed to maintain the alpha-kinase domain of the other subunit in a catalytically competent conformation ( Figure 1B) .
Tyr-1553 and Arg-1558 in the activation sequence make key contacts with the other subunit. The side chain of Tyr-1553 is wedged in between the αA helix of the exchanged segment and the core alpha-kinase domain of the second subunit, where it makes non-polar contacts with Arg-1558 in the αA helix and with Tyr-1756 and Thr-1757 in the second subunit ( Figure 3B ). Replacement of Tyr-1553 with leucine or alanine resulted in a significant loss of kinase activity, showing that hydrophobic interactions play a key role in maintaining catalytic activity. The Y1553A mutant was considerably more active than the Tyr-1553 truncation mutant (33 % versus 7 % wild-type activity), indicating that even a small hydrophobic residue at this position helps to support catalytic activity. A hydrogen bond between the phenolic hydroxy group of Tyr-1553 and Glu-1760 in the other subunit is also likely to be involved in sustaining catalytic activity, since substitution of a phenylalanine for Tyr-1553 produced a 30 % decrease in kinase activity. Replacement of Arg-1558 in the exchanged segment and/or Glu-1760 in the second subunit with alanine produced a greater than 80 % loss of activity, demonstrating that the inter-subunit salt bridge between these two residues plays a central role in the support of kinase activity.
Tyr-1756, Thr-1757 and Glu-1760 make up part of a sharp turn that connects helix D to the β12-strand in the core alpha-kinase domain ( Figure 3B ). The β12 strand is followed immediately by Asp-1765, an invariant residue in the alpha-kinase family that may function as a general base during catalysis [9] . Mutation of Asp-1765 to asparagine or alanine results in a severe loss of kinase activity [15] . The interactions mediated by Tyr-1553 and Arg-1558 may act to stabilize the conformation of the turn connecting (A) His-tagged TRPM7-1577 was co-expressed in E. coli with wild-type (WT) GST-TRPM7-(1548-1576) or with variants containing the indicated mutations. Cell lysates were purified over a glutathione-Sepharose column as described in the Materials and methods section. Samples of the cell lysate and the material eluted with 20 mM glutathione were subjected to SDS/PAGE and immunoblotted using an anti-His tag antibody (bottom panels). (B) The histogram shows the catalytic activity of the TRPM7-1548 kinase domain carrying the indicated mutation relative to that of wild-type (WT) TRPM7-1548 (*P < 0.005). Kinase assays were carried out as described in the Materials and methods section.
helix D to the β12-strand and thus influence the position of Asp-1765. Even small alterations in the position of the catalytic Asp-1765 residue may be sufficient to switch the TRPM7 alphakinase domain from an active to an inactive state.
Truncation analysis demonstrated that the N-terminal segment between Arg-1563 and Gly-1577 is required for dimer assembly by the TRPM7 alpha-kinase domain. Within this 'dimerization sequence' Leu-1564, Ile-1568 and Phe-1570 were demonstrated by site directed mutagenesis to be essential for dimer formation ( Figure 7A ). Examination of the crystal structure of the TRPM7 alpha-kinase domain dimer shows that all three of these residues make hydrophobic contacts with the core alpha-kinase domain of the symmetry-related subunit. Incorporation of the L1564A, I1568A or F1570A mutations into the TRPM7-1548 alphakinase domain construct resulted in a complete loss of activity ( Figure 7B ). It can be concluded that in the absence of the tight inter-subunit interactions mediated by the dimerization sequence, the activation sequence cannot bind and activate the kinase activity of a second alpha-kinase domain.
The catalytic activity of the monomeric TRPM7-1577 kinase domain was partially rescued in vitro by the addition of the purified exchanged segment [GST-(1548-1576)] or fully rescued in E. coli by co-expression with GST-(1548-1576) ( Figures 6A  and 6D ). The relatively poor recovery of TRPM7-1577 kinase activity in vitro may be due to protein aggregation or to the instability of the monomeric alpha-kinase domain. Nevertheless, the results clearly show that the interaction with the exchanged segment, rather than dimer formation, is the key determinant for kinase activity. Whether the TRPM7 alpha-kinase domain, like other domain-swapped proteins, is able to switch between an active domain-swapped dimer and an active closed monomer conformation, is likely to depend on whether the hinge region is sufficiently long to allow the exchanged segment to fold back upon itself [27] . Dimer formation is not required for other members of the alpha-kinase family to exhibit catalytic activity. The isolated alpha-kinase domain of Dictyostelium MHCK A and the eEF-2K (eukaryotic elongation factor-2 kinase) are both active as monomers [28, 29] . It is intriguing, though, that the sequence immediately N-terminal to the eEF-2K alpha-kinase domain, which functions as a Ca 2+ /calmodulin-binding site, is required for catalytic activity [30, 31] . It is tempting to speculate that the Nterminal sequence activates eEF-2K through interactions similar to those described here for TRPM7, with the exception that it folds back to form a closed monomer conformation. Similarly, it can be speculated that changes in the position or structure of the Nterminal exchanged segment, brought about by phosphorylation or by direct interactions with other proteins, such as myosin II, RACK1 (receptors for activated C-kinase 1) or phospholipase C isoenzymes, might provide a means to regulate TRPM7 kinase activity [15, 17, 22, 32, 33] .
TRPM7, like other members of the TRP superfamily, is believed to function as a tetramer [34] . TRPM7 can assemble into homomeric channels or can co-assemble with TRPM6 to form heteromeric channels [24] [25] [26] . In the present study, co-expression experiments demonstrated that the TRPM6 and TRPM7 alphakinase domains are able to swap N-terminal segments to produce active heterodimers ( Figures 5B and 6D ). This result is consistent with the observation that the amino acid sequences of the two exchanged segments are very similar between Tyr-1553 and Phe-1570 (Tyr-1716 to Phe-1733 in TRPM6) ( Figure 5A ). Indeed, only four conservative substitutions (Val-Ile, Ser-Thr, Val-Thr and Val-Ile) occur throughout the critical activation and dimerization sequences of the exchanged segments. The results indicate that heteromeric ion channels composed of TRPM6 and TRPM7 are likely to contain functional homodimeric and heterodimeric alpha-kinase domains.
In summary, the present study shows for the first time that dimer interactions are required for TRPM7 kinase activity and provides new insights into the molecular mechanisms that regulate the kinase activity of this physiologically important ion channel.
